International Journal of Pharmacognosy and Pharmaceutical Sciences

Vol. 4, Issue 2, Part A (2022)

Role of clinical pharmacist in tobacco cessation

Author(s):

S Karunavardhan, M Apoorva, T Anjali, S Suvedha, S Saran Kumar and D Hepcy Kalarani

Abstract:

Habitual to tobacco usage is a major contributor to morbidity and mortality. World health organization predicted that more than 500 million people alive today would killed by 2030 and tobacco consumption will become the single leading cause of death. According to a report from the Indian Council of Medical Research, there are 184 million tobacco users in India, which include 40 million cigarette smokers, 80 million beedi smokers and 60 million using chewable forms of tobacco. In India, tobacco use among the male and female population had estimated to be around 23.2% and 4% in urban and 33.6% and 8.8% in rural areas, respectively. In India, cigarette smoking comprises a small part of the tobacco-smoking problem, the major is beedi smoking, and a large part of the overall tobacco problem is the oral use of smokeless tobacco products. The first step towards a tobacco-free society includes anti-tobacco education and medical help for those willing to quit. Smokers who quit before they are aged 35 yrs. can expect a life expectancy similar to those who have never smoked. Pharmacists are effective providers of tobacco cessation program ultimately helping more patients to become tobacco free and live healthier lifestyles.

Pages: 54-57  |  16 Views  9 Downloads

How to cite this article:
S Karunavardhan, M Apoorva, T Anjali, S Suvedha, S Saran Kumar and D Hepcy Kalarani. Role of clinical pharmacist in tobacco cessation. Int. J. Pharmacognosy Pharm. Sci. 2022;4(2):54-57. DOI: 10.33545/27067009.2022.v4.i2a.92
Call for book chapter